Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank29
3Y CAGR-62.8%
5Y CAGR-58.2%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-62.8%/yr
Annual compound
5Y CAGR
-58.2%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
4 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.05 | -82.9% |
| 2023 | 0.32 | -58.1% |
| 2022 | 0.75 | -28.1% |
| 2021 | 1.05 | -91.4% |
| 2020 | 12.14 | +188.9% |
| 2019 | 4.20 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |